Ivonescimab shows survival benefit in lung cancer study
Go back to Ivonescimab shows survival benefit in lung cancer study| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 17.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.54 | 52 Week High | $19.75 | |||
| Open | $17.54 | 52 Week Low | $4.26 | |||
| Day High | $17.54 | P/E | N/A | |||
| Day Low | $17.54 | EPS | $0.00 | |||
| Volume | 13,578 | |||||

